Windtree's cardiogenic shock medicine istaroxime met its phase 2 trial endpoint – FierceBiotech
Windtree's cardiogenic shock medicine istaroxime met its phase 2 trial endpoint FierceBiotech Source link
Tag: Windtree039s
POPULAR NEWS
EDITOR'S PICK
Windtree's cardiogenic shock medicine istaroxime met its phase 2 trial endpoint FierceBiotech Source link